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Discovering the Pathophysiology of Reperfusion Injury After Myocardial Ischemia
Rachel Fetrow, RN MSN
Otterbein University, Westerville, Ohio
Introduction and Background
Myocardial infarction remains a leading cause of death in the United States. Lack of
blood flow to the heart causes an imbalance between oxygen supply and demand
resulting in damage to the myocardium. Timely restoration of blood flow is the first line
treatment to prevent tissue injury. However, the process of reperfusion can itself
induce cardiomyocyte death, known as myocardial reperfusion injury (Hausenloy &
Yellon, 2013)
Sudden reintroduction of molecular oxygen to energy starved tissue results in a
unique type of injury response that is not manifested during the period of hypoxic
stress. The discovery of this reoxygenation-dependent injury response, which is now
commonly called “reperfusion injury”, opened a new field of research that, despite
many therapeutic strategies, is just being translated to bedside care. (Granger &
Kvietys, 2015).
I chose this topic because the pathophysiology of reperfusion injury can lead to
extensive damage and poor clinical outcomes. According to Frank et al., 2012,
myocardial ischemia reperfusion injury accounts for up to 50% of the final size of a
myocardial infarct. Myocardial damage contributes to significant comorbidities and
patient quality of life is dramatically influenced by the amount of preserved myocardial
function after ischemia. The following information presented will outline the
pathophysiology of myocardial reperfusion injury and the clinical implications for
nursing care.

Significance of Reperfusion Injury
⟡
Cardiomyocyte death
Reperfusion-induced death of
cardiomyocytes that were viable at the
end of the index ischemic event is
defined as lethal myocardial
reperfusion injury. The existence of
lethal myocardial reperfusion injury
has been inferred in both
experimental MI models and in
patients with STEMI by the
observation that therapeutic
interventions applied solely at the
onset of myocardial reperfusion
reduced infarct size significantly
(Hausenloy & Yellon, 2013). One study
demonstrated a 36% reduction in MI
size in reperfused-STEMI patients
randomized to receive ischaemic postconditioning. (Frolich et al 2013).
Illustration: Players involved in ischemia
reperfusion injury (Ibanez et al, 2015)
⟡
Ventricular Function
An increasing number of patients are developing heart failure.
Understanding the implications of reperfusion injury to preserve LV
systolic function and prevent the onset of heart failure may facilitate
the discovery of new effective therapies for reducing MI size and
preventing heart failure in patients presenting with reperfused
STEMI (Bullock, Yellon and Hausenloy 2016). For this reason,
therapeutic interventions for reducing reperfusion injury have been
a viable target for cardioprotection in clinical practice

Signs and Symptoms
⟡
Reperfusion Arrythmia The most
common reperfusion arrhythmia is
accelerated idioventricular (AIVR),
however ventricular premature
contractions, sustained or non-sustained
episodes of V-Tach, A-fib and V-fib are
also observed (Tatli et al, 2013).

Underlying Pathophysiology
What is actually happening?

⟡
Myocardial Stunning Reversible
post-ischemic contractile dysfunction
occurs on reperfusion of acute ischemic
myocardium, resulting from the
detrimental effects of oxidative stress and
intracellular calcium overload on the
myocardial contractile apparatus
(Hausenloy & Yellon, 2013).
⟡
Microvascular obstruction Occurs
because of the vasculature’s inability to
reperfuse the previously ischemic area.
(Hausenloy & Yellon, 2013). Contributing
factors include capillary damage with
impaired vasodilatation, external capillary
compression by endothelial cell and
cardiomyocyte swelling, embolization
from the atherosclerotic plaque, microthrombi, the release of soluble vasomotor
and thrombogenic substances, and
neutrophil plugging. The presence of MVO
is associated with a larger MI size, a lower
LV ejection fraction, adverse ventricular
remodeling, and worse clinical outcomes
(Hausenloy & Yellon, 2013).
⟡
Intramyocardial hemorrhage In
severe cases of MVO extravasation of
blood into the interstitium can produce
intramyocardial hemorrhage within the
area of infarction. It is a severe form of
microvascular obstruction with a
tendency to expand for several hours
after percutaneous coronary intervention.
According to Hamirani, Wong, Kramer
and Salerno, 2015, the cause includes
vascular endothelial damage and
accumulation of red blood cells in the
myocardial extracellular space. Vessels
are injured by the initial ischemia but are
reperfusable at the time of reflow. The
result is a subsequent increase in
intersitial pressure, again compromising
tissue perfusion (Simonis, Strasser and
Ebner 2012). Multiple factors contribute
to the presence and severity of
intramyocardial hemorrhage, including
the amount of collateral flow, ischemic
preconditioning, extent of necrosis, distal
coronary microembolization, and patient
risk factors.

Implications for Nursing Care
STEMI patients with a complete occlusion in a large artery with little coronary
collateralization are most likely to benefit from a therapeutic intervention (Frolich
et al. 2013).
⟡

Ischemic post conditioning therapy. Four-60 second inflations/deflations of
the angioplasty balloon with low pressure upstream from the stent following
deployment has been shown to reduce MI size (Frolich et al 2013). The
protocol for this therapy should be followed within 1 minute of stent
deployment.

⟡

Hyperoxemia and Hypothermia Hyperbaric oxygen reduces MI size by
decreasing tissue edema, reducing formation of lipid peroxide radicals,
altering NO synthase expression and inhibiting leucocyte adherence and
plugging in the microcirculation. Lowering myocardial temperature during
ischemia to 32–33°C can limit MI size in experimental studies by reducing
metabolic demand, inflammatory response, platelet aggregation, and
increasing myocardial efficiency. (Frolich et al, 2013).

⟡

Remote Ischemic Conditioning. Applying three-5 min cycles of brief non-lethal
ischemia and reperfusion using a blood pressure cuff applied to the upper
arm. Applying this RIC protocol to STEMI patients immediately prior to
reperfusion has demonstrated increased myocardial salvage (Simonis et al.
2012). The actual mechanisms, although unclear, have been attributed to a
neuro-hormonal pathway conveying the cardioprotective signal from the limb
to the heart.

⟡

Pharmacologic intervention Is debated due to several therapies that have
proven therapeutic in controlled laboratory settings but unsuccessful in
clinical practice. The following offers insight into pharmacotherapies that
have shown some positive outcome.
• Cyclosporin-A is an immunosuppressant drug that prevents the
formation of the MPTP by binding with cyclo D (Sivaraman & Yellon, 2013).
• Atrial natriuretic peptide. Administering atrial natriuretic peptide (ANP)
at reperfusion reduced MI size through the activation of pro-survival
signaling pathways. Carperitide reduced MI size and preserved LV ejection
fraction in reperfused-STEMI patients. (Frolich et al, 2013).
•Exenatide, a glucagon-like peptide-1 (GLP-1) agonist has demonstrated
reduced MI size when administered at the time of reperfusion and has been
successfully translated in the clinical setting. (Frolich et al, 2013).

Figure: Schematic of main proponents of myocardia acute ischemic
reperfusion injury (Hausenloy & Yellon, 2013)
⟡
Inflammation Neutrophils block
capillaries preventing reperfusion of the
tissue, leading to tissue necrosis and an
exacerbated immune response. Secretion
of proinflammatory cytokines and
chemokines recruite and activate
neutrophils (Schofield, Woodruff, Halai,
Chia-Lun Wu, & Cooper, 2013) This, as
well as membrane expression of celladhesion molecules, induces leukocyte
infiltration within the myocardial tissue.
These leukocytes have the potential to
release large amount of reactive oxygen
species, contributing to further tissue
damage. (Braunersreuther & Jaquet,
2012)
⟡
Oxidative Stress. Influx of oxygen
introduced during reperfusion. Unpaired
electrons formed during the normal
metabolism of oxygen accumulate due to
an excessive reintroduction of oxygen.
ROS overwhelm the endogenous
elimination mechanism by antioxidants.
This oxidative stress results in
impairment of normal function of
circulating molecules. (Braunersreuther
& Jaquet, 2012).

⟡
Intracellular pH changes
Interruption of oxygen supply leads to
arrest of mitochondrial oxidative
phosphorylation and loss of the major
source of ATP generation for metabolic
energy” (Braunersreuther & Jaquet,
2012). Anaerobic glycolysis takes over
and produces hydrogen ions and
lactate, leading to intracellular acidosis.
At reperfusion, physiological pH is
rapidly restored by the washout of
lactate and the activation of the Na+-H+
exchange. This pH shift contributes to
the MPTP opening and ultimately
cardiomyocyte death (Hausenloy &
Yellon, 2013).
⟡
Calcium overload. The calcium
overload is likely related to the effects
of oxidative stress on the sarcolemmal
Ca2+-pump ATPase, and Na+-K+
ATPase, leading to decreased efflux and
increased influx of calcium. It also
depresses the sarcoplasmic reticulum
Ca2+-pump ATPase. These Ca2+
transport system dysfunctions
ultimately lead to intracellular calcium
overload. (Braunersreuther & Jaquet,
2012).

⟡
Mitochondria transition pore opening Oxidative stress, calcium overload and
intracellular change in pH all interact with each other to allow mitochondrial
permeability transition pore (MPTP) opening. The MPTP is a nonselective channel of the
inner mitochondrial membrane. Upon reperfusion, restoration of oxygen rapidly
improves mitochondrial membrane potential, stimulating additional calcium influx,
uncoupling of oxidative phosphorylation and the opening of the MPTP. (Shluter, 2016, p.
230). According to Simonis et al 2012 this phenomenon does not occur in ischemia but is
a key determinant in the first few minutes of myocardial reperfusion. This ultimately
contributes to uncontrolled activation of the contractile machinery leading to
hypercontracture and cardiomyocyte death. (Hausenloy & Yellon, 2013).

Conclusion
Although the process of
myocardial reperfusion has been
optimized following a STEMI, the
process of restoring coronary blood
flow can induce cardiomyocyte death,
thereby mitigating the full benefits of
reperfusion in terms of MI size
reduction. Therapeutic intervention
administered solely at the time of
myocardial reperfusion can reduce MI
size by up to half, limiting incidence of
LV remodeling and heart failure.
Several molecular targets have been
discussed in the influence of potential
successful therapeutic management,
however, standard clinical practice
protocols are continuing to develop
for optimal reperfusion injury
prevention.
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